Managing Acne in Individuals with Polycystic Ovarian Syndrome
Main Article Content
Abstract
Acne vulgaris is a prevalent, long-lasting skin condition that affects individuals aged 15 to 40. It appears to be a common ailment that occurs during adolescence. Nevertheless, it frequently impacts adults as well. Polycystic ovarian syndrome (PCOS) is a prevalent cause of acne vulgaris in adult women. The presence of hyperandrogenism and metabolic problems in this condition may lead to the development of comedones, papules, and nodules on the face, chest, and back. This article specifically examines the current therapies for acne that are linked to polycystic ovarian syndrome.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Allahbadia, G. N., & Merchant, R. (2011). Polycystic ovary syndrome and impact on health. Middle East Fertility Society Journal, 16(1), 19-37.
II. Deswal, R., Narwal, V., Dang, A., & Pundir, C. S. (2020). The prevalence of polycystic ovary syndrome: a brief systematic review. Journal of human reproductive sciences, 13(4), 261-271.
III. Bellver, J., Rodríguez-Tabernero, L., Robles, A., Muñoz, E., Martínez, F., Landeras, J., ... & Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF). (2018). Polycystic ovary syndrome throughout a woman’s life. Journal of assisted reproduction and genetics, 35, 25-39.
IV. Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019). Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. Journal of the Endocrine Society, 3(8), 1545-1573.
V. Xie, L., Hamblin, M. R., Zheng, D., & Wen, X. (2024). The role of microcomedones in acne: Moving from a description to treatment target?. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(1), 9-16.
VI. Kamangar, F., & Shinkai, K. (2012). Acne in the adult female patient: a practical approach. International journal of dermatology, 51(10), 1162-1174.
VII. Thiboutot, D. (2004). Acne: hormonal concepts and therapy. Clinics in dermatology, 22(5), 419-428.
VIII. Wang, R., & Mol, B. W. J. (2017). The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?. Human Reproduction, 32(2), 261-264.
IX. Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., ... & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature reviews Disease primers, 2(1), 1-18.
X. Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565-4592.
XI. Bruner, B., Chad, K., & Chizen, D. (2006). Effects of exercise and nutritional counseling in women with polycystic ovary syndrome. Applied physiology, nutrition, and metabolism, 31(4), 384-391.
XII. Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565-4592.
XIII. Karkera, S., Agard, E., & Sankova, L. (2023). The clinical manifestations of polycystic ovary syndrome (PCOS) and the treatment options. European Journal of Biology and Medical Science Research, 11(1), 57-91.
XIV. Vrbikova, J., & Cibula, D. (2005). Combined oral contraceptives in the treatment of polycystic ovary syndrome. Human reproduction update, 11(3), 277-291.
XV. Rapisarda, A., Brescia, R., Sapia, F., Valenti, G., Sarpietro, G., Di Gregorio, L. M., ... & Monaco, C. (2019). Combined oral contraceptive in adolescent and young adult women: Current evidence and future perspectives. Current Women's Health Reviews, 15(2), 109-118.
XVI. Antoniou-Tsigkos, A., Pastroma, K., Memi, E., Vrachnis, N., & Mastorakos, G. (2022). Combined oral contraceptives: Why, when, where?. In Polycystic Ovary Syndrome (pp. 135-152). Elsevier.
XVII. Zeng, X., Xie, Y. J., Liu, Y. T., Long, S. L., & Mo, Z. C. (2020). Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clinica chimica acta, 502, 214-221.
XVIII. De Jesus, S., Gianos, E., McNally, S. T., Scantlebury, D. C., & Rosen, S. E. (2021). Sex hormones and their impact on cardiovascular health. In Sex Differences in Cardiac Diseases (pp. 539-565). Elsevier.
XIX. Giorgetti, R., Di Muzio, M., Giorgetti, A., Girolami, D., Borgia, L., & Tagliabracci, A. (2017). Flutamide-induced hepatotoxicity: ethical and scientific issues. European Review for Medical & Pharmacological Sciences, 21.
XX. Ranosz, K., & Malara, B. (2021). Opinions of clients of cosmetology salons regarding the impact of wearing protective masks on the condition of the skin. Aesth Cosmetol Med, 10(5), 217-223.